BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3194850)

  • 1. DNA content in radiation-associated thyroid cancer.
    Komorowski RA; Deaconson TF; Vetsch R; Cerletty JM; Wilson SD
    Surgery; 1988 Dec; 104(6):992-6. PubMed ID: 3194850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytometric DNA measurements of thyroid carcinomas].
    Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
    Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma.
    Joensuu H; Klemi PJ
    Am J Clin Pathol; 1988 Jan; 89(1):35-40. PubMed ID: 3337050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of cellular DNA content in thyroid tumors by the flow cytometer].
    Motomura Y
    Nihon Geka Gakkai Zasshi; 1988 Jul; 89(7):1066-74. PubMed ID: 3221827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochemical assessments of the nuclear DNA distribution pattern by means of image and flow cytometry in thyroid neoplasms and in non-neoplastic thyroid lesions. A comparative methodological study.
    Wallin G; Askensten U; Bäckdahl M; Grimelius L; Lundell G; Auer G
    Acta Chir Scand; 1989; 155(4-5):251-8. PubMed ID: 2800873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study.
    Wallin G; Bäckdahl M; Tallroth-Ekman E; Lundell G; Auer G; Löwhagen T
    Eur J Surg Oncol; 1989 Feb; 15(1):43-8. PubMed ID: 2465188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
    Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
    Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms.
    Schelfhout LJ; Cornelisse CJ; Goslings BM; Hamming JF; Kuipers-Dijkshoorn NJ; van de Velde CJ; Fleuren GJ
    Int J Cancer; 1990 Jan; 45(1):16-20. PubMed ID: 2298499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of flow cytometric DNA determination combined with fine needle aspiration biopsy in thyroid tumors.
    Joensuu H; Klemi PJ; Eerola E
    Anal Quant Cytol Histol; 1987 Aug; 9(4):328-34. PubMed ID: 3663313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow cytometric DNA content analysis in thyroid carcinoma].
    Zuo LF
    Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):106-9. PubMed ID: 1879287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cellular DNA content on survival in differentiated thyroid cancer.
    Joensuu H; Klemi P; Eerola E; Tuominen J
    Cancer; 1986 Dec; 58(11):2462-7. PubMed ID: 3768841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of lymph node metastases in well-differentiated and medullary thyroid cancer: retrospective study on 52 cases].
    Antonelli AR; Piazza C; Lombardi D; Casigli F
    Ann Ital Chir; 2004; 75(3):305-14. PubMed ID: 15605518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear DNA content of the tall cell variant of papillary carcinoma of the thyroid gland.
    Stern Y; Medelia O; Feinmesser M; Shpitzer T; Feinmesser R; Segal K
    Ann Otol Rhinol Laryngol; 1996 Sep; 105(9):713-5. PubMed ID: 8800058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nuclear DNA content in small thyroid papillary carcinomas determined by microfluorometry].
    Omata K; Naoe S; Tanaka N
    Gan No Rinsho; 1987 Feb; 33(2):119-24. PubMed ID: 3560446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A flow cytometric deoxyribonucleic acid analysis of papillary thyroid carcinoma.
    Johannessen JV; Sobrinho-Simões M; Tangen KO; Lindmo T
    Lab Invest; 1981 Oct; 45(4):336-41. PubMed ID: 7300245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA alterations in thyroid cancer.
    Tong BC; Ha PK; Dhir K; Xing M; Westra WH; Sidransky D; Califano JA
    J Surg Oncol; 2003 Mar; 82(3):170-3. PubMed ID: 12619060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic value of flow cytometric DNA measurements in follicular tumors of the thyroid gland.
    Greenebaum E; Koss LG; Elequin F; Silver CE
    Cancer; 1985 Oct; 56(8):2011-8. PubMed ID: 4027931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA measurements on cell nuclei of normal, proliferating and neoplastic thyroid tissues in rats.
    Christov K; Thomas C; Sandritter W
    Neoplasma; 1975; 22(3):285-94. PubMed ID: 1161121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of nuclear DNA content in thyroid diagnosis.
    Bengtsson A; Malmaeus J; Grimelius L; Johansson H; Pontén J; Rastad J; Akerström G
    World J Surg; 1984 Aug; 8(4):481-6. PubMed ID: 6485348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.